全体要約
関連する質問
14.6 Billion USD (2021)
15.94% (2022-2027)
Agilent Technologies, Inc., bioMérieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., Thermo Fisher Scientific Inc.
慢性疾患の増加、がんの早期検出、マイクロ流体技術の進歩
概要
目次
Description
Table of Contents
